- Home
- IVA vs UFG Comparison
IVA vs UFG Comparison
Compare IVA & UFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVA
- UFG
- Stock Information
- Founded
- IVA 2011
- UFG 2021
- Country
- IVA France
- UFG Singapore
- Employees
- IVA N/A
- UFG N/A
- Industry
- IVA Biotechnology: Pharmaceutical Preparations
- UFG Oil Refining/Marketing
- Sector
- IVA Health Care
- UFG Energy
- Exchange
- IVA Nasdaq
- UFG Nasdaq
- Market Cap
- IVA 162.8M
- UFG 190.6M
- IPO Year
- IVA 2020
- UFG 2025
- Fundamental
- Price
- IVA $3.90
- UFG $4.63
- Analyst Decision
- IVA Strong Buy
- UFG
- Analyst Count
- IVA 4
- UFG 0
- Target Price
- IVA $10.50
- UFG N/A
- AVG Volume (30 Days)
- IVA 23.7K
- UFG 907.7K
- Earning Date
- IVA 03-26-2025
- UFG 01-01-0001
- Dividend Yield
- IVA N/A
- UFG N/A
- EPS Growth
- IVA N/A
- UFG N/A
- EPS
- IVA N/A
- UFG 0.01
- Revenue
- IVA $14,591,573.00
- UFG $155,193,013.00
- Revenue This Year
- IVA $15.38
- UFG N/A
- Revenue Next Year
- IVA $24.22
- UFG N/A
- P/E Ratio
- IVA N/A
- UFG $880.28
- Revenue Growth
- IVA N/A
- UFG 129.69
- 52 Week Low
- IVA $1.53
- UFG $3.50
- 52 Week High
- IVA $4.05
- UFG $6.13
- Technical
- Relative Strength Index (RSI)
- IVA 69.86
- UFG N/A
- Support Level
- IVA $3.69
- UFG N/A
- Resistance Level
- IVA $4.05
- UFG N/A
- Average True Range (ATR)
- IVA 0.25
- UFG 0.00
- MACD
- IVA 0.07
- UFG 0.00
- Stochastic Oscillator
- IVA 86.96
- UFG 0.00
About IVA Inventiva S.A. American Depository Shares
Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.
About UFG Uni-Fuels Holdings Limited Class A Ordinary Shares
Uni-Fuels Holdings Ltd is a service provider of marine fuels solutions. The company market, resell and brokers marine fuels products such as VLSFO, HSFO, and MGO. It offers these products to shipping companies and marine fuels suppliers in-port and offshore. In addition, the company may from time to time provide shipping-related services to its customers including but not limited to the arrangement of ship agents, ship provisions and marine fuels surveyors. It operates an integrated business model where It serves its customers through two operating models, sales of marine fuels solutions and brokerage.